The use of mycophenolate mofetil in treating patients with non responding aplastic anemia

Aplastic anemia is a relatively uncommon disease and conventional management options include immunosuppressive drugs and/or haematopoeitic stem cell transplantation. It is now known that the pathogenesis of aplastic anemia is immune mediated. Mycophenolate mofetil is a common immunosuppressive drug...

Full description

Bibliographic Details
Main Authors: Gan, Gin Gin, Leong, C.F., Sangkar, J.V., Teh, A., Goh, K.Y., Cheong, S.K.
Format: Article
Language:English
Published: Malaysian Medical Association 2005
Subjects:
Online Access:http://eprints.um.edu.my/24590/1/Aplastic_Anemia.pdf
_version_ 1825722276964728832
author Gan, Gin Gin
Leong, C.F.
Sangkar, J.V.
Teh, A.
Goh, K.Y.
Cheong, S.K.
author_facet Gan, Gin Gin
Leong, C.F.
Sangkar, J.V.
Teh, A.
Goh, K.Y.
Cheong, S.K.
author_sort Gan, Gin Gin
collection UM
description Aplastic anemia is a relatively uncommon disease and conventional management options include immunosuppressive drugs and/or haematopoeitic stem cell transplantation. It is now known that the pathogenesis of aplastic anemia is immune mediated. Mycophenolate mofetil is a common immunosuppressive drug now used mainly in prophylaxis of graft rejection in organ transplant and also for prevention/treatment for graft versus host disease in haemtopoeitic stem cell transplantation. It is thought that mycophenolate mofetil may be useful in this group of patients. In this short report, mycophenolate mofetil was tried in 6 patients who had severe aplastic anemia with variable doses for a minimum duration of 9 months. The result has however not been encouraging.
first_indexed 2024-03-06T06:03:12Z
format Article
id um.eprints-24590
institution Universiti Malaya
language English
last_indexed 2024-03-06T06:03:12Z
publishDate 2005
publisher Malaysian Medical Association
record_format dspace
spelling um.eprints-245902020-06-03T06:58:22Z http://eprints.um.edu.my/24590/ The use of mycophenolate mofetil in treating patients with non responding aplastic anemia Gan, Gin Gin Leong, C.F. Sangkar, J.V. Teh, A. Goh, K.Y. Cheong, S.K. R Medicine Aplastic anemia is a relatively uncommon disease and conventional management options include immunosuppressive drugs and/or haematopoeitic stem cell transplantation. It is now known that the pathogenesis of aplastic anemia is immune mediated. Mycophenolate mofetil is a common immunosuppressive drug now used mainly in prophylaxis of graft rejection in organ transplant and also for prevention/treatment for graft versus host disease in haemtopoeitic stem cell transplantation. It is thought that mycophenolate mofetil may be useful in this group of patients. In this short report, mycophenolate mofetil was tried in 6 patients who had severe aplastic anemia with variable doses for a minimum duration of 9 months. The result has however not been encouraging. Malaysian Medical Association 2005 Article PeerReviewed text en http://eprints.um.edu.my/24590/1/Aplastic_Anemia.pdf Gan, Gin Gin and Leong, C.F. and Sangkar, J.V. and Teh, A. and Goh, K.Y. and Cheong, S.K. (2005) The use of mycophenolate mofetil in treating patients with non responding aplastic anemia. Medical Journal of Malaysia, 60 (3). pp. 311-313. ISSN 0300-5283, http://www.e-mjm.org/2005/v60n3/Aplastic_Anemia.pdf
spellingShingle R Medicine
Gan, Gin Gin
Leong, C.F.
Sangkar, J.V.
Teh, A.
Goh, K.Y.
Cheong, S.K.
The use of mycophenolate mofetil in treating patients with non responding aplastic anemia
title The use of mycophenolate mofetil in treating patients with non responding aplastic anemia
title_full The use of mycophenolate mofetil in treating patients with non responding aplastic anemia
title_fullStr The use of mycophenolate mofetil in treating patients with non responding aplastic anemia
title_full_unstemmed The use of mycophenolate mofetil in treating patients with non responding aplastic anemia
title_short The use of mycophenolate mofetil in treating patients with non responding aplastic anemia
title_sort use of mycophenolate mofetil in treating patients with non responding aplastic anemia
topic R Medicine
url http://eprints.um.edu.my/24590/1/Aplastic_Anemia.pdf
work_keys_str_mv AT gangingin theuseofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia
AT leongcf theuseofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia
AT sangkarjv theuseofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia
AT teha theuseofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia
AT gohky theuseofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia
AT cheongsk theuseofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia
AT gangingin useofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia
AT leongcf useofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia
AT sangkarjv useofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia
AT teha useofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia
AT gohky useofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia
AT cheongsk useofmycophenolatemofetilintreatingpatientswithnonrespondingaplasticanemia